Kennel/cattery vacc protocols (Stone) Flashcards
(95 cards)
1
Q
Max health and production
A
- minimize stress (good and bad)
- ideal housing
- good nutrition
- parasite control
- disease prevention
2
Q
Handle animals in order of….
A
- age and immune status
- puppies, preggos, young adults, adults, sick animals
3
Q
Immunoprophylaxis
A
- enhanceet of a specific immune response in an attempt to protect an animal from disease
- vaccination
- passive transfer
4
Q
Innate immunity
A
- exists prior to foreign Ag exposure
- physical barriers, phagocytic cells, natural killer cells
5
Q
Acquired Immunity
A
- Develops upon a foregn Ag stimulation
- Humoral Immunity B-cells (antibodies)
- Cell mediated Immunity T-cells
- Secretory IgA
6
Q
Passive Immunization
A
- artificial transfer of specific antibodies
- immediate protection
- allergic/immune reactions
- short-lived resistance
- transfer of disease possible
- oral, IM, IP, SQ
7
Q
Active Immunization
A
- give an Ag to produce an immune response
- costs less than passive immunization
- takes time to produce immunity
- long lived immunity
- months, years, life
8
Q
Maternal Antibodies
A
- Colostral antibodies: 82-98%
- Transplacental Antibodies: 2-18%
- Absorbed in 1st 24-72 hours
9
Q
offsprings antibody level affected by
A
- maternal antibody titer
- amount of colostrum received
- parasitism
- environment
10
Q
critical period
Test question
A
- Elimination of maternal antibody in the neonate in relation to vaccination
- 6-8
- 14-16 weeks
11
Q
Modified-live Attenuated
A
- whole agent
- recombinant vector
12
Q
Inactivated/non-infectious
A
- whole agent - killed
- purified subunit
- recombinant protein
13
Q
Advantages of modified-live vaccines
A
- replicate in host
- provide more rapid protection
- produce longer-lasting immunity
- lower Ag mass - fewer reactions
- better stimulates CMI
14
Q
Disadvantages Modified-Live Vaccines
A
- Reversion to virulence (very rare)
- immunosuppressed
- neonates
- Can cause immune suppression
- all the vet students across the street…lol
15
Q
Recombinant Vector
A
- Genetic code for key immunogenic proteins inserted into a non-pathogenic vector
- Pox virus, herpesvirus, bovine papillomavirus, simian virus 40, adenovirus
- PUREVAX (Rabies, FeLV) - Merial (Cats)
- Recombitek Distemper - Merial (Dogs)
16
Q
Intranasal or Oral
modified live
A
- Immune response within 3-5 days
- higher levels of IgA
- Readily reverts to varulence
- More post vaccinal signs (IN)
17
Q
Parenteral
Modified Live Products
A
- Immune response within 7-10 days
- high levels of IgG
- Does not revert to virulence as readily
- fewer post vaccinl signs
18
Q
Advantages of inactivated vaccines (whole agent)
A
- Don’t replicate in host
- no reversion to virulence
- safer in immunosuppressed or neonates
19
Q
Disadvantages of Inactivated vaccines (whole agent)
A
- requires more vaccinations
- more allergenic due to higher Ag mass
- requires adjuvant
- shorter duration of immunity (DOI)
- initial protection requires a booster
20
Q
Purified subunit
(inactivated vaccines)
A
- Purified antigenic components of the infectious agent
- less allergenic than killed whole agent
- Leukocell 2 - Zoetis (cats)
21
Q
Recombinant protein
(inactivated vaccines)
A
- Desired gene clonged into organism, produced in vitro then harvested
- Recombitek Lyme - Merial
22
Q
Adjuvants
A
- added to increase duration and amount of immunostimulation
- Types
- aluminum hydroxide
- mycobacteria/endotoxins
- carbopol
- oil
- liposomes
- freund’s complete
23
Q
Vaccination does not equal
A
immunization
24
Q
Categories of vaccine failure
A
- Host factors
- Vaccine factors
- Human factors
25
Host factors
* immunodeficiency
* maternal Ab
* Age
* Pregnancy
* Fever/hypothermia
* stress/illness
* incubating disease
* drug therapy
* general debilitation
* malnutrition
* hormonal changes
26
Vaccine factors
* improper storage/handling
* biological variation
* strain differences
* excessive attenuation
* reversion to virulence
* overwhelming exposure
27
Human factors
* hospital protocol
* vaccine interference
* 2 week interval
* improper mixing/amount
* exposed at time of vaccination
* improper route of admin
* improper use of disinfectants
* concurrent use of microbials or immunosuppressive drugs
28
steroids and vaccination
* ok to vaccinate an animal on steroids for inflammation
* not ok to vaccinate an animal on immunosuppressive doses steroids
29
Vaccination reactions
* local
* mild systematic
* fetal resorption, abortions, birth defects
* immune complex disease
* anaphylaxis
* immune mediated hemolytic anemia (or thrombocytopenia)
* Vaccine induced neoplasia
* contamination of multidose vials
* adventitious agents
* febrile limping syndrome of acats
* vaccine assoc disease of young akitas
* incomplete attenuation causing disease
30
Core vaccines dogs
* canine distemper virus
* canine parvovirus
* infectious canine hepatitis
* rabies
31
core vaccines cats
* rabies
* feline panleukopenia
* feline herpes virus
* feline calicivirus
32
Non-core vaccines dogs
* given based on risk assessment
* canine corona virus
* canine parainfluenza virus
* leptospirosis
* bordetella
* lyme
* influenza
33
Non-core vaccines cats
* Feline Leukemia (core in kittens)
* FIV
* FIP
* Chlamydophila
* bordetella (zoonotic to peeps too)
34
Risk assessment
* shelters/breeders
* outdoor enthusiast
* outdoor socialite
* indoor socialite
* indoor elitist
* indoor pampered pet
35
Canine
* Transmission
* virus shed in body secretions
* primary source of exposure: aerosol
* often young dogs kept in groups
* virus shedding ceases 1-2 weeks post-recovery
* virus labile
* survives hours to days
36
Canine distemper
CS
* chorioretinitis + keratoconjunctivitis + CNS signs = pretty unique to distemper
* other signs
* respiratory
* GI
* CNS signs: seizures, ataxia, myoclonus
37
Canine distemper
DX
* Clinical signs/inadequate vaccine history
38
Canine distemper
Prevention
* MLV most common
* **vaccinate on intake to group housing situation**
* vaccinate at 6-8 weeks then q 2-4 weeks until 14-16 weeks
* booster in 1 year then q 1-3 years depending on risk
39
Distemper
recombinant vector
* Recombitek CDV at first vaccine (merial)
* more rapid immunity, booster annualy
* long term immunity when boostered with attenuated virus vaccine
* Many shelters use this when they can afford it
40
Infectious Canine Hepatitis
(Canine Adenovirus Type I (CAV-1)
Transmission
* oronasal
* shed in all secretions
* shed 6-9 months in urine post recovery
* **resistant to inactivation and disinfection**
41
Infectious canine hepatitis
CS
* Per acute: death within hours
* Acute
* 5-7 day course
* V/D abdominal pain
* Corneal edema (blue eye)
* Anterior uveitis
* CNS signs
* hepatic encephalopathy
* hypoglycemia or non-suppurative encephalitis
42
Infectious canine hepatitis
DX
* **clincal signs in unvaccinated dogs \< 1 yr old**
43
Infectous canine hepatitis
Prevention
* MLV
* Canine adenovirus type 1 vaccine
* can cause anterior uveitis/nephritis
* don't use this
* **CAV-2 vaccine**
* cross protection without reaction
* **vaccinate on intake to group housing**
* vaccinate at 6-8 weeks then q 2-4 weeks until 14-16 weeks
* booster in 1 year then q 1-3 yrs depending on risk
44
Canine Leptospirosis
Transmission
* Direct contact
* urine
* veneral
* placenta
* bites
* ingesting tissue
* Indirect contact
* contaminated water, bedding, soil
* recent flooding
\*Rodent and wild animal reservoirs
45
Canine leptospirosis
CS
* Fever, depression, anorexia, muscle mpain
* dehydration, congested mucous membranes
* acute renal failure
* acute hepatic failure
* DIC
46
Canine Leptospirosis
DX
* **serology: microscopic agglutination test**
* **4-fold rising titer**
* **not a great test**
47
Lepto immunization reduces ..... and .... not ......
reduces **incidence** and **severity** not carrier state
48
Duration of lepto immunity (**killed** whole agent)
Newer vaccines with purified proteins/subunits last
about 8 months
12 months
49
Allergenicity of Lepto vaccine
* historically highly allergenic
* anaphylaxis: treat and discontinue use
* avoid in mini dachshunds
* combo with other killed products \> anaphylaxis
50
Lepto vaccination schedule
* no cross protection between serovars
* vaccinate at \>/= 9 weeks then q 2-4 weeks for 2-3 doses
* As adults: q 6-12 months depending on risk
* 2 serovar vaccine not recommended
* 4 serovar one is recommended by AVMA
* **important in any at risk animal**
51
Canine Infectious Trachebronchitis
(Canine cough complex)
causes
* Virus
* parainfluenza
* adenovirus type-2
* canine distemper
* canine herpesvirus
* canine influenza
* Bacteria
* bordetella bronchiseptica
* streptococcus
* mycoplasmas
52
Canine Infectious Tracheobronchitis
Transmission
* Highly contagious via aerosol spread
* fomite transmission
* incubation period 5-7 days (3-10)
* **group confinement is a risk factor**
53
Canine infectious tracheobronchitis
CS
* mild - death
* summer and fall
* paroxysmal, honking cough
* gagging/retching
* inc w/activity
* cough elicited by tracheal palpation
* BAR
54
Canine infectious tracheobronchitis
DX
* clinical signs and exposure history
* culture-nasal or tracheobronchial swabs
* rads
* bact pneum looks different than viral pneum
* cytology
55
Parainfluenza prevention
(usually a commensal thing)
Intranasal
* Intranasal
* IgA, MLV
* less maternal interference
* rapid protection, post vaccinal signs
* 1 dose at \> 3 weeks of age or 7-14 days pre-board
56
Parainfluenza prevention
Parenteral
* 2 doses, 2-4 weeks apart
* MLV
* Takes longer for protection
* reduces clinical signs, not shedding
* less post vaccinal signs
57
Bordetella bronchiseptial prevention
Nasal or oral
* live avirulent
* given w/ parainfluenza
* IgA w/in 4 days
* protects against clinical dz and shedding
* mild signs post vaccine
* 1 dose \> 3 weeks or 7-14 days pre-board
* **no booster required....?**
* **acts like a real infection, body boosters itself**
* **stimulates all types of immunity**
58
Bordetella bronchiseptica prevention
Parenteral
* Killed
* 2 doses, 2-4 wks apart or 7-14 days pre-board
* vaccine reaction possible
* **only stimulating antibody reponse**
* **booster required**
## Footnote
**\*Zoonotic potential: recommend for owners that are immunosupressed**
59
Canine influenza
* Influenza H3N8 and novel H3N2
* Respiratory illness similar to kennel cough
* can progress to life-threatening pneumonia
* no seasonal comp
* no relation to parainfluenza and no cross protection
60
Canine Influenza vaccine
* vaccination of susceptible dogs and quarantine and iso infected dogs
* vaccine (merck and Zoetis)
* inactivated virus
* adjuvant
* aid in control of disease
* reduces severity and length of illness
* reduces shedding and shedding interval
61
Canine parvovirus
Transmission
* CPV-2 late 1970s
* CPV-2a and CPV-2b since 1980
* Transmission
* fecal-oral
* virus survives many months
* fomite and environmental contamination
* signs begin in 4-7 days
* disease in pups \< 1 year old
* esp \< 6 mo
62
Canine Parvo
CS
* GI
* Endotoxemia, sepsis, hypothermia
63
Canine parvo
DX
* CBC: leukopenia 500-2000/mcl
* virology: ELISA (SNAP)
* for fecal excretion of CPV-2
* vaccination can interfere with test
64
canine parvo
prevention
* maternal Ab interference
* vaccinate out to 16 weeks of age
* **vaccinate on intake to group housing**
* period of susceptibility
* killed & MLV
* MLV better protection
65
Canine Coronavirus
* almost always subclinical infection so dogs will develop own immunity
* not sure why we vaccinate for it
* not recommended for use
66
Lyme disease
types of vaccines
* killed whole cell
* recombinant outer surface protein (Osp A)
* Bacterin (Osp A, C)
67
Lyme disease
prevention
* tick control
* vaccination in groups at risk
68
Canine Rabies
about
* Know rabies laws where you are
* incidence in cats \> dogs
* virus labile outside of host
69
Canine rabies
CS
* death usually in 3-7 days
* Prodromal phase 2-3 days
* erratic behavior, fever, slow corneal and palpebral reflexes
* Furious phase 2-4 days
* irritable, barking, aggression, ataxia, seizure
* Paralytic phase 2-4 days
* paresis, paralysis, change in bark, drooling, coma
* atypical
70
Canine Rabies
DX
* **Submit animals head (CHILLED, NOT FROZEN)**
* Direct fluorescent antibody test (DFA)
* Histopath (negri bodies)
* Mouse inoculation for confirmation
71
Rabies
vaccination schedule
* vaccinate at 12-**16** weeks and repeat in 1 year
* repeat in 1 yr if unsure of previous vaccine
* Some 1 & 3 yr vaccines are same, some are different
* killed vaccine highly adjuvanted:
* granulomas
* ear tip necrosis
72
Feline upper respiratory disease
causes
* virus
* herpesvirus
* calicivirus
* bacteria
* chlamydophila
* bordetella
* mycoplasmas
* mycoplasma
73
Herpes virus and calicivirus
transmission
* Direct contact: oral, nasal, ocular
* Fomites
* FHV-susceptible, survives 18-24 hours
* FCV-resistant, survives 8-10 days
* Aerosol
* sneeze can be propelled 4 feet
74
Herpes virus and calicivirus
CS
* anorexia
* depression
* fever
* oro-nasal d/c
75
FHV
CS
* URI signs more sever, secondary bacterial infection
* corneal involvement
* intermittent shedding post infection
76
FCV
CS
* oral ulceration, more mild URI
* myalgia/arthralgia
* persistent shedding
77
Herpesvirus and calicivirus prevention
* vaccination only lessens clinical signs
* vaccinate at 6-8 weeks then q 2-4 weeks until 14-16 weeks
* **vaccinate on intake to group housing**
* revaccinate in 1 year then q 1-3
*
78
Herpesvirus and calicivirus
Types of vaccines
* MLV and killed, parenteral
* MLV, intranasal
* quicker immunity
* consider in outbreak
* causes CS
79
Chlamydophila felis
* causes conjunctivitis
* stone doesn't vaccinate for it, treats it if it happens (AB)
* endemic in UK they use vaccine
80
Bordetella
* only a prob in catteries
81
Feline Panleukopenia
CS
DX
* CS
* parvo virus in cats
* targets rapidly dividing cells
* adult infection: subclinical
* kittens: same as parvo
* neonates: cerebellar hypoplasia, thymic atrophy, fading kitten syndrome
* DX
* CS
82
Feline Panleukopenia
Prevention
* If you can vaccinate out to 16 weeks of age you can protect for life
* vaccinate at 6-9 weeks then q 2-4 weeks until 12-16 weeks
* revaccinate in 1 year and then q 1-3 yrs
* **vaccination on intake to group housing**
83
Feline Leukemia
Transmission
* intimate oro-nasal contact w/infected saliva
* transplacental
* milk borne (more common)
* Virus survives 24-48 hours in environment
84
Feline Leukemia
CS
* Lymphoma, Leukemia
* immunodeficiency
* infertility, stillbirths, abortions
85
Feline leukemia
DX
* snap tests looking for antigen
* ELISA, Screening
* IFA, confirmatory
* PCR
86
Feline Leukemia Prevention
* test before vaccination then in 2-3 months if high risk
* most important in group housing
* adjuvants in cats cause: fibrosarcoma
87
Feline Immunodeficiency virus
* Lentivirus
* primary bite wounds
* simple iso for FIV+ cats
88
Feline Immunodeficiency Virus
DX
* SNAP combo
* in house antibody test
* western blot
* PCR, virus iso
89
Feline Immunodeficiency Virus
Prevention
* record (chip, or notch) vaccinated animals because they will always test positive after the vaccination
90
Feline Infectious Peritonitis
* can't prevent it with vaccination
* FIP can survive 7 weeks in environment, fomite transmission
* Risk factors
* 6 mos-2yrs, then \> 10
* purebreds
* **group confinement**
* concurrent infection (FeLV, FIV)
91
FIP
CS
* Fever, anorexia, weight loss, kitten mortality
* effusive (wet) form
* vasculitis causes abd/thoracic effusion
* non-effusive (dry) form
* multifocal pyogranulomatous inflammation
* liver, kidney, spleen, eyes, nervous system
92
FIP
vaccine
* do environmental control
* vaccine wont help
93
Feline rabies
* dog product can be used in cats (but there are adjuvants)
* merial purevax
* cats feel ick after 3 yr rabies
94
objectives of vaccination
* vaccinate largest possible number of animals in population at risk
* vaccinate each animal no more frequently than necessary
* vaccinate only against infectious agents to which individuals have a realistic risk of exposure, infection and disease
* vaccinate only when the potential benefits of procedure outweigh potential risks
95
To know
1. window of susceptibilitiy
2. priority of handling
3. immunophrophylaxis
4. core vs non-core
5. partnership for healthy pets exits
6. why do we do preventative care
7. tools of preventative care